Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,873 | 55 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $880.57 | 19 | $0 (2019) |
| ABBVIE INC. | $511.33 | 23 | $0 (2024) |
| Cook Medical LLC | $202.06 | 2 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $117.05 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $104.53 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $43.18 | 3 | $0 (2024) |
| PFIZER INC. | $14.15 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $264.76 | 14 | ABBVIE INC. ($220.34) |
| 2023 | $382.19 | 17 | ABBVIE INC. ($290.99) |
| 2022 | $228.30 | 4 | Cook Medical LLC ($202.06) |
| 2019 | $392.92 | 5 | Boston Scientific Corporation ($392.92) |
| 2018 | $271.93 | 5 | BOSTON SCIENTIFIC CORPORATION ($271.93) |
| 2017 | $332.77 | 10 | BOSTON SCIENTIFIC CORPORATION ($215.72) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: VACCINES | ||||||
| 07/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.27 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: VACCINES | ||||||
| 04/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Gastroenterology | ||||||
| 03/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $80.11 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Gastroenterology | ||||||
| 07/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: RESPIRATORY | ||||||
| 07/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.43 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Gastroenterology | ||||||
| 06/06/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Daniel Han, MD
Dr. Daniel Han, MD is a Urology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2013. The National Provider Identifier (NPI) number assigned to this provider is 1609211366.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Han, MD has received a total of $1,873 in payments from pharmaceutical and medical device companies, with $264.76 received in 2024. These payments were reported across 55 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,873).
Practice Information
- Specialty Urology
- Other Specialties Pediatric Urology
- Location Palo Alto, CA
- Active Since 05/07/2013
- Last Updated 03/13/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1609211366
Products in Payments
- QULIPTA (Drug) $285.75
- ZILVER PTX (Device) $202.06
- GENERAL THERAPIES (Device) $150.30
- UBRELVY (Drug) $128.71
- AMS 700 (Device) $127.18
- GENERAL BPH (Device) $125.12
- SOLYX BLUE (Device) $125.00
- XIAFLEX (Biological) $117.05
- GENERAL KIDNEY STONE DISEASE (Device) $111.20
- SPECTRA (Device) $105.59
- VRAYLAR (Drug) $96.87
- SHINGRIX (Biological) $78.26
- ADVANCE (Device) $60.66
- XIFAXAN (Drug) $43.18
- GENERAL - KIDNEY STONE DISEASE (Device) $29.82
- AREXVY (Drug) $26.27
- LITHOVUE (Device) $23.06
- SWISS LITHOCLAST ULTRA (Device) $22.64
- ELIQUIS (Drug) $14.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Palo Alto
Daniel Yao, M.d, M.D
Urology — Payments: $8,208
William Brubaker, Md, MD
Urology — Payments: $3,910
Dr. Yuka Yamaguchi, M.d, M.D
Urology — Payments: $3,577
Keith Lee, Md, MD
Urology — Payments: $3,085
Andrew Epstein, Md, MD
Urology — Payments: $592.82
Kathleen Kan, Md, MD
Urology — Payments: $511.81